FDA Recalls Chorionic Gonadotropin Syringes Due to Sterility Concerns
The FDA is recalling 834 syringes of Chorionic Gonadotropin compounded by Moses Lake Professional Pharmacy because the agency cannot ensure the product is sterile.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of assurance of sterility in an injectable drug, which poses a significant risk of serious injury or infection.
Plain-English summary
The U.S. Food and Drug Administration (FDA) has issued a recall for 834 syringes of Chorionic Gonadotropin, Injectable Solution, 175 UNITS/1.5mg per syringe with Methylcobalamin. The product is compounded by JD & SN Inc., dba Moses Lake Professional Pharmacy, located in Moses Lake, Washington. The recall is classified as Class II by the FDA.
The reason for the recall is a lack of assurance of sterility. The source text indicates that all sterile human compounded drugs within their expiry dates are affected by this issue. The specific lot codes associated with the recalled units are listed in the product metadata.
Consumers who have this product should stop using it and contact their healthcare provider or the pharmacy for further instructions. The recall is distributed nationwide.
The recalled product
- Product
- CHORIONIC GONADOTROPIN, Injectable Solution,175 UNITS/1.5mg per syringe with Methylcobalamin, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA 98837, (509)764-2314
- Category
- Drug — Compounded Injectable
- Affected units
- 834
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (18)
- 04292015@12
- 05042015@8
- 05202015@21
- 06102015@25
- 06242015@14
- 07012015@8
- 07062015@21
- t03062015@15
- t03122015@33
- t03182015@45
- t03192015@2
- t04082015@14
- t04082015@3
- t04202015@22
- t05082015@27
- t05192015@29
- t06022015@37
- and t07152015@5.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 101 recalled by JD & SN Inc., dba Moses Lake Professional Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 101 products in this recall →Related recalls
Same manufacturer · JD & SN Inc., dba Moses Lake Professional Pharmacy
See all →- SevereFDA Recalls Estradiol Pellets Due to Lack of Sterility Assurance
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Sodium Tetradecyl Sulfate Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Six Trimix Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Compounded Chorionic Gonadotropin Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Compounded Progesterone Pellets Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29